BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

34 hedge funds and large institutions have $5.29M invested in BRAINSTORM CELL THERAPUTC in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

26% less capital invested

Capital invested by funds: $7.11M → $5.29M (-$1.82M)

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$129K
2
+$70K
3
+$40K
4
EMG
ETF Managers Group
New Jersey
+$16K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$15.8K

Top Sellers

1
-$216K
2
-$210K
3
-$208K
4
Renaissance Technologies
Renaissance Technologies
New York
-$80.3K
5
ARTA
A.R.T. Advisors
New York
-$65K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6K
27
$5K
28
$4K
29
$2K
30
$1K
31
$1K
32
$1K
33
$1K
34
$473
35
–
36
–
37
–
38
–
39
–
1
2